Saikosaponin B2

TypeName: Business Offer
Category:
Offer Date:2018/03/05
Country: United States
Summary: Saikosaponin B1 is extracted from the herb of Bupleurum chinense DC. It acted on HCV E2. It inhibited infection by several genotypic strains and prevented binding of serum-derived HCV onto hepatoma cells.
www.bocsci.com/saikosaponin-b2-cas-58316-41-9-item-5-464414.html
Description: We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.
OfferId: 1204
Name:Alex Brown
Telphone:
Categories